Pure Global

LIAISON® Q.S.E.T. Device Plus - India CDSCO Medical Device Registration

LIAISON® Q.S.E.T. Device Plus is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000360_c7e21e1429ed76d72f9b7878e6bf5410_3a191d6c336652a536bc4c15f0425b17. This device is marketed under the brand name LIAISON® Q.S.E.T. Device Plus. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class A. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class A
LIAISON® Q.S.E.T. Device Plus
UID: IMP/IVD/2022/000360_c7e21e1429ed76d72f9b7878e6bf5410_3a191d6c336652a536bc4c15f0425b17

Brand Name

LIAISON® Q.S.E.T. Device Plus

Device Class

Class A

Approving Authority

CDSCO

Product Information

The LIAISON® Q.S.E.T. Device Plus (LIAISON® Q.S.E.T. Device Plus) is intended for use in the preparation of human stool specimens for testing in designated stool assays. The device is intended for in vitro diagnostic use in a professional laboratory setting on the automated LIAISON® Analyzer family.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing